Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 4291-63-8 Chemical Structure| 4291-63-8

Structure of Cladribine
CAS No.: 4291-63-8

Chemical Structure| 4291-63-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cladribine is an adenosine deaminase inhibitor used to treat hairy cell leukemia and multiple sclerosis. For U266, RPMI8226, and MM1.S cells, its IC50 are approximately 2.43 μM, 0.75 μM, and 0.18 μM, respectively.

Synonyms: 2-Chloro-2′-deoxyadenosine; CldAdo; 2CDA

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cladribine

CAS No. :4291-63-8
Formula : C10H12ClN5O3
M.W : 285.69
SMILES Code : [C@@H]3([N]2C1=C(C(=NC(=N1)Cl)N)N=C2)O[C@H](CO)[C@H](C3)O
Synonyms :
2-Chloro-2′-deoxyadenosine; CldAdo; 2CDA
MDL No. :MFCD00153939
InChI Key :PTOAARAWEBMLNO-KVQBGUIXSA-N
Pubchem ID :20279

Safety of Cladribine

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H341-H361-H372
Precautionary Statements:P201-P202-P260-P264-P270-P280-P301+P310+P330-P308+P313-P405-P501
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Cladribine

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02096055 Leukemia Phase 2 Active, not recruiting April 2026 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00691652 Lymphoma Phase 1 Phase 2 Terminated - United States, Oregon ... More >> Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 Less <<
NCT00117598 Lymphoma Phase 3 Completed - -
NCT01364363 Severe Aplastic Anemia ... More >> Paroxysmal Nocturnal Hemoglobinuria Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Myeloproliferative Syndromes Chronic Myelogenous Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Multiple Myeloma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Large Granulocytic Leukemia Less << Not Applicable Recruiting January 2023 United States, California ... More >> Scripps Green Hospital Recruiting La Jolla, California, United States, 92037 Contact: Carol Burian    858-554-2845    Burian.Carol@scrippshealth.org    Principal Investigator: Jeffrey W. Andrey, MD Less <<
NCT00117598 - Completed - -
NCT00199017 Lymphoma, Lymphoblastic Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00198991 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD    ++49(0)69 6301 5194    hoelzer@em.uni-frankfurt.de    Contact: Nicola Goekbuget, MD    ++49(0)69 6301 6365    goekbuget@em.uni-frankfurt.de    Principal Investigator: Dieter Hoelzer, MD,PhD          Sub-Investigator: Nicola Goekbuget, MD Less <<
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT00691652 - Terminated - -
NCT00004904 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous/Nonmalignant Condition Small Intestine Cancer Less << Phase 1 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT02676856 Acute Myeloid Leukemia Not Applicable Unknown August 2018 China, Guangdong ... More >> Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Fen Huang    +86-020-62787883    13826204917@163.com Less <<
NCT02665065 Acute Myeloid Leukemia ... More >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute Less << Phase 3 Recruiting June 2020 United States, Arizona ... More >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada Less <<
NCT00001567 Hairy Cell Leukemia Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00708721 Cancer Chroni... More >>c Myelomonocytic Leukemia Less << Phase 1 Phase 2 Terminated(Data analysis revea... More >>led sufficient data for safety and efficacy) Less << - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00708721 - Terminated(Data analysis revea... More >>led sufficient data for safety and efficacy) Less << - -
NCT02425904 Langerhans Cell Histiocytosis Phase 2 Recruiting September 2022 United States, Arizona ... More >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85016 Contact: Michael Henry, MD    602-933-0920    MHenry@phoenixchildrens.com    United States, Arkansas Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Kimo Stine, MD    501-364-1494    StineKimoC@uams.edu    United States, California Children's Hospital of Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Rima Jubran, MD    323-361-5639    rjubran@chla.usc.edu    University of California San Francisco Medical Center Recruiting San Francisco, California, United States, 94143 Contact: Michelle Hermiston, MD    415-476-3831    HermistonM@peds.ucsf.edu    United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Stephen Ladisch, MD       sladisch@childrensnational.org    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: David Ebb, MD    617-726-2737    DEBB@mgh.harvard.edu    Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Barbara Degar, MD    617-632-5186    Barbara_Degar@dfci.harvard.edu    Principal Investigator: Barbara Degar, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Barbara Degar, MD    617-632-5186    barbara_degar@dfci.harvard.edu    Principal Investigator: Barbara Degar, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Eric Jacobsen, MD    617-632-6633    EdJacobsen@partners.org    United States, New York Mount Sinai Medical Center Recruiting New York, New York, United States, 10029 Contact: Birte Wistinghausen, MD    212-241-7022    Birte.wistinghausen@mssm.edu    United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Ashish Kumar, MD    513-803-1631    Ashish.Kumar@cchmc.org    United States, Pennsylvania The Children's Hospital of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Michael Hogarty, MD    215-590-2821    hogartym@email.chop.edu    United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Patrick Campbell, MD       patrick.campbell@stjude.org    Principal Investigator: Patrick Campbell, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carl Allen, MD    832-822-4890    ceallen@txch.org Less <<
NCT01534702 Acute Myeloid Leukemia Phase 1 Phase 2 Unknown September 2015 Germany ... More >> Universitätsklinikum Düsseldorf Not yet recruiting Düsseldorf, Germany, 40225 Contact: Andrea Kuendgen, MD       andrea.kuendgen@med.uni-duesseldorf.de    Principal Investigator: Andrea Kuendgen, MD          Klinikum Essen-Werden Recruiting Essen, Germany, 45239 Contact: Mohammad Wattad, MD       m.wattad@kliniken-essen-sued.de    Principal Investigator: Mohammad Wattad, MD          Universitätsklinikum Freiburg Recruiting Freiburg, Germany, D-79106 Contact: Michael Luebbert, MD       luebbert@mm11.ukl.uni-freiburg.de    Principal Investigator: Michael Luebbert, MD          Universitätsklinikum Hamburg-Eppendorf Not yet recruiting Hamburg, Germany, 20246 Contact: Walter Fiedler, MD       fiedler@uke.uni-hamburg.de    Principal Investigator: Walter Fiedler, MD          Hannover Medical School Recruiting Hannover, Germany, D-30625 Contact: Juergen Krauter, MD    +49-511-532-3720    Krauter.Juergen@MH-Hannover.de    Principal Investigator: Juergen Krauter, MD          Klinikum Rechts der Isar Not yet recruiting Muenchen, Germany, 81675 Contact: Justus Duyster       justus.duyster@lrz.tum.de    Principal Investigator: Justus Duyster, MD          Universitätsklinikum Ulm Not yet recruiting Ulm, Germany, 89081 Contact: Richard Schlenk, MD       Richard.Schlenk@uniklinik-ulm.de    Principal Investigator: Richard Schlenk, MD Less <<
NCT03150004 Acute Myeloid Leukemia Phase 2 Recruiting June 1, 2020 United States, Wisconsin ... More >> Froedtert & the Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Medical College of Wisconsin Clinical Cancer Center    414-805-8900    cccto@mcw.edu Less <<
NCT00028418 Hematologic Neoplasms ... More >> Lymphoproliferative Disorders Leukemia Leukemia, Lymphocytic, Chronic Less << Phase 1 Completed - United States, Texas ... More >> University of Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02883946 - Completed - France ... More >> Chu de Reims Reims, France, 51092 Less <<
NCT01334996 - Recruiting October 2020 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55901 Contact: Joseph H Butterfield, MD    507-284-3783    butterfield.joseph@mayo.edu Less <<
NCT02205762 Langerhans Cell Histiocytosis Phase 2 Phase 3 Recruiting July 2023 United States, Arizona ... More >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85006 Contact: Michael Henry, MD       mhenry@phoenixchildrens.com    Principal Investigator: Michael Henry, MD          United States, Arkansas Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Kimo Stine, MD       stinekimoc@uams.edu    Principal Investigator: Kimo Stine, MD          United States, California Children's Hospital of Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Rima Jubran, MD       rjubran@chla.usc.edu    Principal Investigator: Rima Jubran, MD          Valley Children's Healthcare Not yet recruiting Madera, California, United States, 93636 Contact: David Samuel, MD       DSamuel@valleychildrens.org    Contact: Faisal Razzaqi, MD       FRazzaqi@valleychildrens.org    Principal Investigator: David Samuel, MD          United States, Connecticut Connecticut Children's Medical Center Not yet recruiting Hartford, Connecticut, United States, 06106 Contact: Andrea Orsey, MD       aorsey@connecticutchildrens.org    Principal Investigator: Andrea Orsey, MD          United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Stephan Ladisch, MD       sladisch@childrensnational.org    Contact: Jay Greenberg, MD       jagreenb@childrensnational.org    United States, Maryland Johns Hopkins University Not yet recruiting Baltimore, Maryland, United States, 21287 Contact: Elias Zambidis, MD       EZambid1@jhmi.edu    Contact: Christine Pratilas, MD       Cpratil1@jhmi.edu    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Mary Huang, MD    617-726-2737    mshuang@partners.org    Principal Investigator: Mary Huang, MD          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Barbara Degar, MD    617-632-6801    bdegar@partners.org    Principal Investigator: Barbara Degar, MD          United States, Minnesota Children's Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Michael Richards, MD       Michael.richards@childrensmn.org    Contact: Nathan Gossai, MD       nathan.gossai@childrensmn.org    United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Steven Diamond, MD       Steven.Diamond@hackensackmeridian.org    Contact: Burton Appel, MD       Burton.appel@hackensackmeridian.org    United States, New York Cohen Children's Medical Center Recruiting New Hyde Park, New York, United States, 11040 Contact: Carolyn Fein Levy, MD       clevy4@northwell.edu    Contact: Jeffery Lipton, MD       jlipton@northwell.edu    Columbia University / Herbert Irving Cancer Center Recruiting New York, New York, United States, 10032 Contact: Maria Luis Sulis, MD       mls95@cumc.columbia.edu    Contact: Julia Glade Bender, MD       jg589@cumc.columbia.edu    Staten Island University Hospital Recruiting Staten Island, New York, United States, 10305 Contact: Sarah Vaiselbuh, MD    718-226-6435    svaiselbuh@nshs.edu    Principal Investigator: Sarah Vaiselbuh`, MD          SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Melanie Comito, MD       comitom@upstate.edu    Contact: Andrea Dvorak, MD       dvoraka@upstate.edu    United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Michael Jordan, MD    513-636-1773    Michael.jordan@cchmc.org    Contact: Ashish Kumar, MD    513-803-1631    ashish.kumar@cchmc.org    United States, South Carolina Medical Universtiy of South Carolina/Hollings Cancer Center Not yet recruiting Charleston, South Carolina, United States, 29425 Contact: Jacqueline Kraveka, DO    843-792-2957    kravekjm@musc.edu    Principal Investigator: Jacqueline Kraveka, DO          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Patrick Campbell, MD       patrick.campbell@stjude.org    Principal Investigator: Patrick Campbell, MD          United States, Washington Providence Sacred Heart Children's Hospital Recruiting Spokane, Washington, United States, 99204 Contact: Stefanos Intzes, MD       stefanos.intzes@providence.org    Contact: Judy Felgenhauer, MD       judy.felgenhauer@providence.org Less <<
NCT02272478 Acute Myeloid Leukaemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Phase 3 Recruiting October 2020 United Kingdom ... More >> UHW Recruiting Cardiff, United Kingdom, CF14 4XN Principal Investigator: Steve Knapper          Nottingham University Hospital Recruiting Nottingham, United Kingdom Contact: Nigel Russell, MD Less <<
NCT00002805 Leukemia Phase 2 Completed - -
NCT02072811 Acute Myeloid Leukemia Phase 3 Unknown February 2018 Poland ... More >> Copernicus Memorial Hospital Recruiting Lodz, Poland, 93-510 Principal Investigator: Agnieszka Wierzbowska, Dr hab. n. med. Less <<
NCT03257241 Acute Myeloid Leukemia Phase 3 Recruiting December 31, 2020 Poland ... More >> Medical University of Bialystok Clinical Hospital Recruiting Białystok, Poland, 15-276 Contact: Jarosław Piszcz, Dr          Markiewicz Memorial Oncology Center Brzozow Recruiting Brzozów, Poland, 36-200 Contact: Andrzej Pluta, Dr          University Clinical Centre in Gdansk Recruiting Gdańsk, Poland, 80-210 Contact: Maria Bieniaszewska, Dr          Holycross Cancer Center Recruiting Kielce, Poland, 25-001 Contact: Marzena Wątek, Dr          Ludwik Rydygier Memorial Specialized Hospital Recruiting Kraków, Poland, 30-001 Contact: Małgorzata Raźny, Dr          Regional Specialised Hospital in Legnica Recruiting Legnica, Poland, 59-220 Contact: Jadwiga Hołojda          Independent Public University Hospital No. 1 in Lublin Recruiting Lublin, Poland, 20-001 Contact: Marek Hus, Prof.          Clinical Hospital at the Karol Marcinkowski Medical University in Poznan Recruiting Poznań, Poland, 60-355 Contact: MAciej Kaźmierczak, Dr          Copernicus Memorial Hospital in Lodz Comprehensive Cancer Center and Traumatology Recruiting Łódź, Poland, 93-513 Contact: Agnieszka Wierzbowska, Prof.    +48426895191    agawierzbowska@wp.pl Less <<
NCT00136084 Leukemia, Myelocytic, Acute Phase 3 Completed - United States, California ... More >> Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Children's Hospital of Michigan (Wayne State University) Detroit, Michigan, United States, 48201 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 MD Anderson Cancer Center Houston, Texas, United States, 77030 Texas Children's Cancer Center Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00136084 - Completed - -
NCT02756572 Blasts 10 Percent or More of B... More >>one Marrow Nucleated Cells Chronic Myelomonocytic Leukemia-2 High Grade Malignant Neoplasm Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts-2 Myeloid Neoplasm Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mary-Elizabeth M. Percival    206-606-1320    mperciva@seattlecca.org    Principal Investigator: Mary-Elizabeth M. Percival Less <<
NCT00955916 Leukemia Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00111345 Myeloid Leukemia Phase 2 Phase 3 Unknown March 2017 Germany ... More >> University Children's Hospital Muenster, Department of Paediatric Haematology and Oncology Muenster, North Rhine-Westphalia, Germany, D-48129 Less <<
NCT02416908 Acute Myeloid Leukemia Phase 1 Phase 2 Active, not recruiting June 30, 2019 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00955916 - Completed - -
NCT00594555 Chronic Myeloid Leukemia, Blas... More >>t Crisis Acute Myeloid Leukemia Less << Phase 2 Withdrawn(Principal Investigat... More >>or resigned position with the University of Cincinnati, closing study at this site will reopen study in new position) Less << November 2008 United States, Ohio ... More >> University of Cincinnati Cincinnati, Ohio, United States, 45267 Less <<
NCT00002833 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03441048 Acute Myeloid Leukemia Phase 1 Recruiting April 1, 2020 United States, Wisconsin ... More >> Froedtert Hospital and the Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Cancer Center Clinical Trials Office    866-680-0505 ext 8900    cccto@mcw.edu    Principal Investigator: Sameem Abedin, MD Less <<
NCT03589729 Acute Myeloid Leukemia ... More >> Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Blasts 10 Percent or More of Bone Marrow Nucleated Cells High Risk Myelodysplastic Syndrome Myeloid Sarcoma Myeloproliferative Neoplasm Philadelphia Chromosome Positive Less << Phase 2 Recruiting December 31, 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Maro Ohanian    713-792-2631       Principal Investigator: Maro Ohanian Less <<
NCT00199030 Adult Acute Lymphocytic Leukem... More >>ia T-Cell Lymphoma, Lymphoblastic Less << Phase 2 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00074048 Leukemia Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT01295593 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Unknown April 2013 Belgium ... More >> Clinique Sud Luxembourg Recruiting Arlon, Belgium, 6700 Contact: Pascal Pierre, MD          Institut Jules Bordet Recruiting Brussels, Belgium, 1000 Contact: Dominique Bron, MD, PhD          ULB Erasme Recruiting Brussels, Belgium, 1070 Contact: Alain Kentos, MD          Cliniques universitaires Saint Luc Recruiting Brussels, Belgium, 1200 Principal Investigator: Eric Van Den Neste, MD, PhD          Grand Hôpital de Charleori - Site notre Dame Recruiting Charleroi, Belgium, 6000 Contact: Marc André, MD          Clinique Notre-Dame de Grâce Recruiting Gosselies, Belgium, 6041 Contact: Marie Maerevoet, MD          Hôpital de Jolimont Recruiting Haine-St-Paul, Belgium, 7100 Contact: Valérie Delrieu, MD          CHU ULg Recruiting Liège, Belgium, 4000 Contact: Bernard De Prijck, MD          Clinique Saint Pierre Recruiting Ottignies, Belgium, 1340 Contact: Thierry Connerotte, MD, PhD          Heilig-Hartziekenhuis Recruiting Roeselaere, Belgium, 8800 Contact: Hilde Demuynck, MD          Cliniques de Mont Godinne Recruiting Yvoir, Belgium, 5530 Contact: Christian Chatelain, MD, PhD Less <<
NCT03369665 Multiple Sclerosis Phase 4 Recruiting November 25, 2021 Austria ... More >> Kepler Universitätsklinikum Recruiting Linz, Austria, 4021 Principal Investigator: Michael Guger          Belgium Hôpital Erasme Recruiting Brussels, Belgium, 1070 Principal Investigator: Gaetano Perrotta          Cliniques Univ. St.-Luc Recruiting Brussels, Belgium, 1200 Principal Investigator: Vincent Van Pesch          UZ Antwerpen Recruiting Edegem, Belgium, 2650 Principal Investigator: Barbara Willekens          Jessa Ziekenhuis Recruiting Hasselt, Belgium, 3500 Principal Investigator: Nina De Klippel          Clinique Saint Pierre Recruiting Ottignies, Belgium, 1340 Principal Investigator: Philippe Jacquerye          Czechia FN u sv. Anny Brno Recruiting Brno, Czechia, 65691 Principal Investigator: Michel Dufek          FN Hradec Kralove Recruiting Chocen, Czechia, 56501 Principal Investigator: Martin Valis          Nemocnice Jihlava, p.o. Recruiting Jihlava, Czechia, 586 33 Principal Investigator: Radek Ampapa          Denmark Aalborg Hospital Recruiting Aalborg, Denmark, 9100 Principal Investigator: Claudia Pfleger          Matthias Kant Recruiting Sønderborg, Denmark, 6400 Principal Investigator: Matthias Kant          Finland Helsinki University Central Hospital Recruiting Helsinki, Finland, 290 Principal Investigator: Annuka Uusitalo          Terveystalo Mikkeli Recruiting Mikkeli, Finland, 50100 Principal Investigator: Sakari Simula          Hungary University of Debrecen Recruiting Debrecen, Hungary, 4032 Principal Investigator: Tünde Csepany          VALEOMED Kft Recruiting Esztergom, Hungary, 2500 Principal Investigator: Maria Satori          Lithuania Hospital of Lithuanian University of Health Sciences Kaunas Recruiting Kaunas, Lithuania, 50161 Principal Investigator: Antanas Vaitkus          Klaipedos Ligonine Recruiting Kaunas, Lithuania, 50161 Principal Investigator: Lina Malciene          Vilnius University Hospital Santariskiu Clinics Recruiting Vilnius, Lithuania, 8661 Principal Investigator: Rasa Kizlaitiene          Netherlands Zuyderland Recruiting Sittard-Geleen, Netherlands, 6131 BG Principal Investigator: Raymond Hupperts          Poland M.A. - LEK A.M.Maciejowscy SC. Recruiting Katowice, Poland, 40-571 Principal Investigator: Maciej Maciejowski          Centrum Medyczne Medyk Recruiting Lublin, Poland, 20-954 Principal Investigator: Halina Bartosik Psujek          Indywidualna Praktyka Lekarska Prof. Konrad Rejdak Recruiting Lublin, Poland, 20-954 Principal Investigator: Konrad Rejdak          Centrum Neurologii K. Selmaj Recruiting Łódź, Poland, 90-153 Principal Investigator: Krzysztof Selmaj Less <<
NCT00019071 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, Maryland ... More >> Radiation Oncology Branch Bethesda, Maryland, United States, 20892 Less <<
NCT02323022 Acute Myeloid Leukemia Phase 3 Recruiting December 2020 China, Jiangsu ... More >> The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215006 Contact: Jia Chen, M.D.    +86 512 6778 1856    chenjiasuzhou@gmail.com Less <<
NCT00003757 Leukemia Phase 2 Completed - Switzerland ... More >> Klinik Hirslanden Zurich, Switzerland, CH-8008 Less <<
NCT03364036 Multiple Sclerosis Phase 4 Recruiting December 31, 2021 Germany ... More >> Merck KGaA Communication Center Recruiting Darmstadt, Germany, 64293 Less <<
NCT01513603 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Burkitts Leukemia/Lymphoma Chronic Myelogenous Leukemia Less << Phase 2 Unknown January 2014 United States, New York ... More >> Westchester Medical Center/New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Karen Seiter, MD    914-493-7514    karen_seiter@nymc.edu    Principal Investigator: Karen Seiter, MD          Sub-Investigator: Delong Liu, MD, PhD          Sub-Investigator: Claudio Sandoval, MD Less <<
NCT03384225 High Risk Acute Myeloid Leukem... More >>ia Allogeneic Hematopoeitic Stem Cell Transplantation Less << Phase 3 Recruiting July 31, 2020 China, Shanghai ... More >> Shanghai general hospital, Shanghai Jiaotong university school of medicine Recruiting Shanghai, Shanghai, China, 200080 Contact: Xingpeng Wang, M.D.,Ph. D.    86-21-63069298    sfph_edu2@163.com    Contact: Yanhong Zhu    86-21-63240090 ext 6213    sfph_edu2@shumu.edu.cn    Sub-Investigator: Jieling Jiang, M.D.          Principal Investigator: Xiaoxia Hu, M.D.          Principal Investigator: Qiang Liu, M.D.          Principal Investigator: Yajing Xu, M.D.          Principal Investigator: Ting Yang, M.D.          Principal Investigator: Huangfang Wang, M.D.          Sub-Investigator: Yang Cao, M.D. Less <<
NCT03602131 Hodgkin Lymphoma ... More >> Non-hodgkin Lymphoma Less << Phase 2 Not yet recruiting March 30, 2021 -
NCT00258271 Leukemia Phase 1 Completed - United States, New York ... More >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT03384212 High Risk Acute Myeloid Leukem... More >>ia Allogeneic Hematopoeitic Stem Cell Transplantation Less << Phase 3 Recruiting July 31, 2020 China, Shanghai ... More >> Shanghai general hospital, Shanghai Jiaotong university school of medicine Recruiting Shanghai, Shanghai, China, 200080 Contact: Xingpeng Wang, M.D.,Ph. D.    86-21-63069298    sfph_edu2@163.com    Contact: Yanhong Zhu    86-21-63240090 ext 6213    sfph_edu2@shumu.edu.cn    Sub-Investigator: Jieling Jiang, M.D.          Principal Investigator: Xiaoxia Hu, M.D.          Principal Investigator: Qiang Liu, M.D.          Principal Investigator: Yajing Xu, M.D.          Principal Investigator: Ting Yang, M.D.          Principal Investigator: Huangfang Wang, M.D.          Sub-Investigator: Yang Cao, M.D. Less <<
NCT01272817 Aplastic Anemia ... More >> Paroxysmal Nocturnal Hemoglobinuria Acute Myelogenous Leukemia Acute Lymphocytic Leukemia Myelodysplastic Syndrome Chronic Myelogenous Leukemia Chronic Lymphocytic Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Mantle Cell Lymphoma Multiple Myeloma Waldenstrom Macroglobulinemia Breast Cancer Renal Cell Carcinoma Melanoma Sarcoma Ovarian Cancer Thymoma Less << Not Applicable Unknown - United States, California ... More >> Scripps Green Hospital Recruiting La Jolla, California, United States, 92037 Contact: Cynthia Nelson, R.N.    858-554-2814    nelson.cynthia@scrippshealth.org    Contact: Laurie Cobarrubia, R.N.    858-554-2853    cobarrubia.laurie@scrippshealth.org    Principal Investigator: Jeffrey W. Andrey, M.D.          Sub-Investigator: James R. Mason, M.D.          Sub-Investigator: William E. Miller, M.D. Less <<
NCT00072007 Leukemia Phase 2 Completed - Switzerland ... More >> Kantonspital Aarau Aarau, Switzerland, 5001 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Inselspital Bern Bern, Switzerland, CH-3010 Spitaeler Chur AG Chur, Switzerland, CH-7000 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital, Luzerne Luzerne, Switzerland, CH-6000 Hopital des Cadolles, Neuchatel Neuchatel, Switzerland, 2000 Praxis Dr. Beretta Rheinfelden, Switzerland, 4310 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Onkozentrum Zurich, Switzerland, 8038 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT03012672 Acute Leukemia of Ambiguous Li... More >>neage Acute Myeloid Leukemia Myeloid Neoplasm Less << Phase 2 Recruiting July 15, 2020 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Anna Halpern    206-667-6233       Principal Investigator: Anna Halpern Less <<
NCT00003178 Leukemia Phase 2 Completed - -
NCT03151876 Lymphoma Phase 2 Recruiting December 2021 China, Beijing ... More >> Beijing cancer hospital Not yet recruiting Beijing, Beijing, China, 100142 Contact: Yan Xie, MD          Peking university third hospital Not yet recruiting Beijing, Beijing, China, 100191 Contact: Xiaoyan Ke, MD          China, Chongqing The first affiliated hospital of Chongqing medical university Not yet recruiting Chongqing, Chongqing, China, 400016 Contact: Lin Liu, MD          Southwest Hospital Recruiting Chongqing, Chongqing, China, 400038 Contact: Dabing Qin, MD          China, Gansu General Hospital of Lanzhou military command Not yet recruiting Lanzhou, Gansu, China, 730070 Contact: Hai Bai, MD          China, Henan Henan cancer hospital Not yet recruiting Zhengzhou, Henan, China, 450008 Contact: Jian Zhou, MD          The first affiliated hospital of Zhengzhou university Not yet recruiting Zhengzhou, Henan, China, 450052 Contact: Xinhua Wang, MD          China, Hubei Tongji Hospital Not yet recruiting Wuhan, Hubei, China, 430030 Contact: Yang Cao, MD          China, Jiangsu Jiangsu province hospital Not yet recruiting Nanjing, Jiangsu, China, 210029 Contact: Wei Xu, MD          China, Shanghai Rui jin hospital Shanghai jiao tong University Not yet recruiting Shanghai, Shanghai, China, 200025 Contact: Jiong Hu, MD          Tong Ren Hospital Not yet recruiting Shanghai, Shanghai, China Contact: Ligen L i u, MD          China, Shanxi Shan Xi Da Yi Hospital Not yet recruiting Taiyuan, Shanxi, China, 030032 Contact: Rong Gong, MD          Tangdu Hospital Not yet recruiting Xi'an, Shanxi, China, 710038 Contact: Qiang Liu, MD          China, Sichuan West China Hospital of Sichuan University Recruiting Chengdu, Sichuan, China, 610044 Contact: Jie Ji, MD    86-28-85422370    jieji@scu.edu.cn    Affiliated Hospital of Southwest Medical University Recruiting Nanchong, Sichuan, China, 646000 Contact: Xiaoming Li, MD          China, Tianjing Blood diseases hospital, Chinese academy of medica Not yet recruiting Tianjin, Tianjing, China, 300020 Contact: Lvgui Qiu, MD          China, Xinjiang The first affiliated hospital of Xinjiang medical Universtiy Not yet recruiting Ürümqi, Xinjiang, China, 830054 Contact: Ming Jiang, MD          China, Yunnan Kunming General Hospital of Chengdu Military Area Not yet recruiting Kunming, Yunnan, China, 650032 Contact: Sanbin Wang, MD Less <<
NCT00641537 Relapsing-Remitting Multiple S... More >>clerosis Less << Phase 3 Completed - -
NCT02910752 Leukemia Phase 1 Phase 2 Recruiting September 2020 China ... More >> Rui Jin Hospital, Department of Hematology Recruiting Shanghai, China, 200025 Contact: Jiong HU, M.D.,    86-21-64370045    hujiong@medmail.com.cn    Contact: Ling Wang, M.D.,    86-21-64370045    cclingjar@163.com Less <<
NCT03585686 Langerhans Cell Histiocytosis Phase 2 Recruiting December 2020 Russian Federation ... More >> Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology Recruiting Moscow, Russian Federation, 117997 Contact: Zhanna Shekhovtsova, MD    4956647078 ext 7538    zhanna.shekhovtsova@fccho-moscow.ru    Contact: Eugene Pashanov, PhD    +79262205578    e.pashanov@gmail.com    Sub-Investigator: Dmitry Evseev, MD          Principal Investigator: Michael Maschan, PhD Less <<
NCT00004762 Cholangitis, Sclerosing Phase 2 Completed - -
NCT00641537 - Completed - -
NCT00718549 Lymphocytic Leukemia, Chronic Phase 3 Completed - Belarus ... More >> City Clinical Hospital #9 Minsk, Belarus, 220116 Poland Medical University, Independent Public Clinical Hospital; Dept. of Hematology, SPSK Bialystok, Poland, 15-276 Szpital Uniwersytecki W Krakowie; Klinika Hematologii Krakow, Poland, 31-501 Medical University School; Dept. of Haematology Lodz, Poland, 93-510 Istytut Hematologii i Transfuzjologii; Hematologia Warszawa, Poland, 02 776 Medical Uni of Wroclaw; Hematology Wroclaw, Poland, 50-367 Less <<
NCT00718549 - Completed - -
NCT02728050 Acute Biphenotypic Leukemia ... More >> Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome High Risk Myelodysplastic Syndrome Myelodysplastic Syndrome Myeloproliferative Neoplasm Less << Phase 1 Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Anna Halpern    206-314-5944    halpern2@uw.edu    Principal Investigator: Anna Halpern Less <<
NCT00003174 Leukemia Phase 1 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48202-1379 Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods, Michigan, United States, 48236 Less <<
NCT00003746 Leukemia Phase 3 Completed - Switzerland ... More >> Inselspital Bern Bern, Switzerland, CH-3010 Less <<
NCT00656812 Lymphoma of Mucosa-Associated ... More >>Lymphoid Tissue Less << Phase 2 Completed - Austria ... More >> Universitätsklinikum Graz Graz, Austria, A-8036 Universitaetsklinik Innsbruck/ Klinik für Innere Medizin Innsbruck, Austria, A-6020 Krankenhaus der Stadt Linz Linz, Austria, A-4020 Universitaetsklinik f. Innere Medizin III Salzburg, Austria, A-5020 AKH Wien / Universitaetsklinik fuer Innere Medizin I Vienna, Austria, A-1090 Less <<
NCT01161550 Leukemia, Myeloid, Acute Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00436826 - Completed - -
NCT00764517 Recurrent B-Cell Non-Hodgkin L... More >>ymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Indolent Adult Non-Hodgkin Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Less << Phase 2 Completed - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Less <<
NCT00667329 Lymphoma Phase 1 Active, not recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00787969 Lymphoma Phase 1 Completed - -
NCT03531918 Acute Myeloid Leukemia ... More >> High-Grade Myeloid Neoplasm Less << Phase 1 Phase 2 Recruiting July 1, 2025 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Roland Walters    206-667-3599    rwalter@fredhutch.org    Principal Investigator: Roland Walters Less <<
NCT00764517 - Completed - -
NCT02921061 Mixed Phenotype Acute Leukemia... More >> Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent High Risk Myelodysplastic Syndrome Refractory Acute Myeloid Leukemia Refractory High Risk Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Sarah A. Buckley    206-416-5066    sbuckley@fredhutch.org    Principal Investigator: Sarah A. Buckley Less <<
NCT00483067 Leukemia Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00053027 Lymphoma Phase 2 Completed - -
NCT00213135 Multiple Sclerosis, Relapsing-... More >>Remitting Less << Phase 3 Completed - -
NCT00436826 Multiple Sclerosis Phase 2 Completed - -
NCT00213135 - Completed - -
NCT00725985 Multiple Sclerosis Phase 3 Completed - -
NCT03586609 Acute Myeloid Leukemia Phase 2 Recruiting January 3, 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Tapan M. Kadia    713-563-3534       Principal Investigator: Tapan M. Kadia Less <<
NCT00725985 - Completed - -
NCT02115295 Leukemia Phase 2 Recruiting May 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02044796 Acute Biphenotypic Leukemia ... More >> de Novo Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Less << Phase 1 Phase 2 Active, not recruiting August 1, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00002879 Lymphoma Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 10309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinical and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Canada, Saskatchewan Saskatchewan Cancer Agency Regina, Saskatchewan, Canada, S4S 6X3 Less <<
NCT00126321 Leukemia, Myelocytic, Acute Phase 2 Unknown March 2011 Germany ... More >> Medical Clinic & Policlinic III, University Bonn Recruiting Bonn, Germany, 53105 Contact: Marie von Lilienfeld-Toal, MD    +49-228-287-22263    m.lilienfeld.toal@uni-bonn.de    Principal Investigator: Marie von Lilienfeld-Toal, MD Less <<
NCT01439750 Mantle Cell Lymphoma Phase 1 Active, not recruiting August 2020 United States, Pennsylvania ... More >> Penn State Cancer Institute Hershey, Pennsylvania, United States, 17033 Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT02250937 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Recruiting October 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00412594 Leukemia Phase 2 Recruiting June 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00980395 Lymphoma Mant... More >>le Cell Lymphoma Indolent Lymphoma SLL Less << Phase 2 Active, not recruiting December 31, 2021 United States, Arizona ... More >> The University of Arizona Cancer Center Tucson, Arizona, United States, 85724-5024 Less <<
NCT01446900 Chronic Lymphocytic Leukaemia ... More >> Small Lymphocytic Lymphoma Less << Phase 2 Terminated(low rate in patient... More >> accrual) Less << - Italy ... More >> European Institute of Oncology Milan, Italy Less <<
NCT01473797 Langerhans Cell Histiocytosis ... More >>of Lung Less << PHASE2 UNKNOWN 2025-04-22 Saint Louis hospital, Paris, 7... More >>5010, France Less <<
NCT00923013 Hairy Cell Leukemia Phase 2 Recruiting December 31, 2018 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT01515527 Leukemia Phase 2 Recruiting February 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01602939 Systemic Mastocytosis Phase 2 Phase 3 Unknown June 2017 Spain ... More >> Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hospital Virgen del Valle Recruiting Toledo, Spain, 45071 Contact: Luis Escribano, MD, PhD    +34925269335    lescribanom@sescam.jccm.es    Contact: Iván Alvarez-Twose, MD    +34925269336    ivana@sescam.jccm.es    Principal Investigator: Luis Escribano, MD, PhD          Sub-Investigator: Iván Alvarez-Twose, MD Less <<
NCT02157181 Hairy Cell Leukemia (HCL) Phase 2 Completed - Germany ... More >> Community based hemato-oncology medical office Ansbach, Germany, 91522 Community based hemato-oncology medical office Aschaffenburg, Germany, 63739 Community based hemato-oncology medical office Celle, Germany, 29221 St.-Johannes-Hospital Dortmund, Germany, 44137 Städtische Kliniken Esslingen Esslingen, Germany, 73728 Universitätsklinik Frankfurt Frankfurt am Main, Germany, 60596 Universitätsklinik Freiburg Freiburg, Germany, 79106 Community based hemato-oncology medical office Fürth, Germany, 90766 University Clinic | Med. Cinic IV Justus-Liebig-University Gießen, Germany, 3592 Wilhelm-Anton-Hospital Goch, Germany, 47574 Kath. Krankenhaus Hagen gem. GmbH Hagen, Germany, 58095 Community based hemato-oncology medical office Halle, Germany, 06108 Community based hemato-oncology medical office Hamburg, Germany, 21073 Meditinische Hochschule (MHH) Hannover, Germany, 30623 Community based hemato-oncology medical office Heidelberg, Germany, 69115 Marienhospital Herne/ Klinikum der Ruhr-Universität Bochum Herne, Germany, 44625 Community based hemato-oncology medical office Hilden, Germany, 40721 Community based hemato-oncology medical office Hildesheim, Germany, 31134 Klinikum Idar-Oberstein Idar-Oberstein, Germany, 55743 Community based hemato-oncology medical office Jena, Germany, 07743 Community based hemato-oncology medical office Kassel, Germany, 34125 Community based hemato-oncology medical office Kiel, Germany, 24105 Community based hemato-oncology medical office Koblenz, Germany, 56068 Community based hemato-oncology medical office Kronach, Germany, 96317 Community based hemato-oncology medical office Leer, Germany, 26789 Community based hemato-oncology medical office Leipzig, Germany, 04103 Städtische Kliniken Leverkusen, Germany, 51375 Community based hemato-oncology medical office Magdeburg, Germany, 39104 Community based hemato-oncology medical office Marburg, Germany, 35037 Klinik Schwäbisch Gmünd / Staufer Klinik Mutlangen, Germany, 73557 Community based hemato-oncology medical office München, Germany, 80335 Community based hemato-oncology medical office München, Germany, 81241 Klinikum Großhadern München, Germany, 81377 Community based hemato-oncology medical office Neunkirchen, Germany, 66538 Community based hemato-oncology medical office Neuwied, Germany, 56564 Community based hemato-oncology medical office Niddatal, Germany, 61194 Community based hemato-oncology medical office Nürnberg, Germany, 90449 MVZ Klinikum Osnabrück Osnabrück, Germany, 49076 Community based hemato-oncology medical office Pforzheim, Germany, 75179 Klinikum Ernst von Bergmann gGmbH Potsdam, Germany, 14467 St. Josefs-Krankenhaus Potsdam, Germany, 14471 Community based hemato-oncology medical office Schweinfurt, Germany, 97421 St. Marien-Krankenhaus Siegen, Germany, 57072 Community based hemato-oncology medical office Straubing, Germany, 94315 Diakonie-Klinikum Stuttgart Stuttgart, Germany, 70176 Community based hemato-oncology medical office Villingen, Germany, 78050 Community based hemato-oncology medical office Wolfsburg, Germany, 38440 Less <<
NCT03491579 AML Relapse Phase 1 Withdrawn(IMP will not be furt... More >>her developed) Less << October 2019 Switzerland ... More >> Departement of Medical Oncology, University Hospital Berne Berne, Switzerland, 3010 Less <<
NCT03181815 Acute Myeloid Leukemia ... More >> Relapse Leukemia Less << Phase 2 Recruiting May 1, 2019 China, Guangdong ... More >> Liang Wang Recruiting Guangzhou, Guangdong, China, 510060 Contact: Liang Wang, M.D.    +862087342439    wangliang@sysucc.org.cn Less <<
NCT03318419 Acute Lymphoblastic Leukemia Phase 2 Recruiting December 31, 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting GuangZhou, Guangdong, China, 510060 Contact: yue lu, MD.    0086-02087342438    dr_luyue@sina.com Less <<
NCT01013350 - Active, not recruiting October 26, 2018 United States, Massachusetts ... More >> Outcome Sciences, Inc Cambridge, Massachusetts, United States, 02139 Less <<
NCT02131753 Hairy Cell Leukemia Phase 2 Phase 3 Recruiting December 2027 -
NCT00938366 Multiple Sclerosis Phase 1 Completed - -
NCT00938366 - Completed - -
NCT03745144 Relapsing Multiple Sclerosis (... More >>RMS) Less << Phase 1 Not yet recruiting January 15, 2020 Germany ... More >> Please Contact the Merck KGaA Communication Center Not yet recruiting Darmstadt, Germany, 64293 Less <<
NCT03235973 Leukemia, Myeloid, Acute ... More >> Leukemia, Lymphoblastic, Acute Less << Phase 1 Recruiting April 2021 France ... More >> Institut Paoli-Calmettes Recruiting Marseille, Bouches-du-Rhône, France, 13009 Contact: Dominique Genre, MD    +33491223778    drci.up@ipc.unicancer.fr    Principal Investigator: Raynier Devillier, MD,PhD Less <<
NCT04178005 Multiple Sclerosis PHASE4 ACTIVE_NOT_RECRUITING 2025-12-26 College Park Family Care Cente... More >>r Physicians Group, Overland Park, Kansas, 66212, United States|UT Southwestern Medical center, Dallas, Texas, 75390, United States Less <<
NCT04679506 Precursor T-Cell Lymphoblastic... More >> Leukemia-Lymphoma Less << UNKNOWN 2025-12-23 -
NCT06021600 Leukemia|Myelodysplastic Syndr... More >>omes|Acute Myeloid Leukemia Less << PHASE1 RECRUITING 2027-12-31 M D Anderson Cancer Center, Ho... More >>uston, Texas, 77030, United States Less <<
NCT04861207 Acute Myeloid Leukemia Myelody... More >>splastic Syndromes Less << PHASE2 UNKNOWN 2025-01-31 Klinika Transplantacji Szpiku ... More >>i Onkohematologii Narodowy Instytut Onkologii im. Marii Sk?odowskiej-Curie Państwowy Instytut Badawczy, Oddzia? w Gliwicach, Gliwice, 44-101, Poland Less <<
NCT03963375 Multiple Sclerosis|Multiple Sc... More >>lerosis, Relapsing-Remitting Less << PHASE4 ACTIVE_NOT_RECRUITING 2025-05-30 Washington University School o... More >>f Medicine, Saint Louis, Missouri, 63110, United States|Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, 73104, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States Less <<
NCT04934800 Multiple Sclerosis COMPLETED 2024-05-20 KH der Barmherzige Brüder Eise... More >>nstadt - Neurology, Eisenstadt, Austria|Dr. Reinhard Krendl-Head, Sankt Veit an der Glan, Austria|Klinik Florisdorf, Wien, Austria|University of Thrace, Medical School - Neurology Department, Alexandroupolis, Greece|251 General Air Force Hospital, Athens, Greece|417 NIMITS Hospital, Athens, Greece|Aeginiteion Hospital, University of Athens - A' Neurology Department, Athens, Greece|Attikon University Hospital, Athens, Greece|Evangelismos Hospital - Neurology Department, Athens, Greece|Genaral Hospital of Elefsina "Thriasio", Athens, Greece|General Hospital of Athens "Evangelismos", Athens, Greece|University of Ioannina - Neurology Department, Ioannina, Ioannina, Greece|University General Hospital of Larissa - Rheumatology Clinic, Larissa, Greece|Iatriko Palaioy Faliroy, Medical Center - Neurology Department, Paleo Faliro, Greece|University General Hospital of Patra, Patras, Greece|General Hospital of Patra "Agios Andreas", Patra, Greece|AHEPA General Hospital of Thessaloniki, Thessaloniki, Greece|General Hospital of Thessaloniki "G. Papanikolaou", Thessaloniki, Greece|Interbalkan Hospital of Thessaloniki, Thessaloniki, Greece|Papageorgiou General Hospital Thessaloniki, Thessaloniki, Greece|St Luke's Hospital, Thessaloniki, Greece|Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Presidio Papa Giovanni XXIII) - Dipartimento di Neurologia, Bergamo, Italy|Fondazione Istituto G.Giglio di Cefalù - Neurologia-Centro Sclerosi Multipla, Cefalù, Italy|Università degli Studi G. D'Annunzio, Chieti, Italy|Azienda Ospedaliera Universitaria Arcispedale Sant'Anna - Neurologia, Cona, Italy|Ospedali Riuniti di Foggia - Neurology, Foggia, Italy|Azienda Socio Sanitaria Territoriale della Valle Olona (presidio di Gallarate) - Neurologia 2 - Sclerosi Multipla, Gallarate, Italy|ASL 1 Avezzano L'Aquila Sulmona- Ospedale Regionale San Salvatore - Dipartimento di Neurologia, L'Aquila, Italy|Ospedale San Luca - S.C.Oncologia, Lucca, Italy|IRCCS Centro Neurolesi Bonino Pulejo - U.O. di Neurofisipatologia ed Ambulatori, Messina, Italy|Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli - U.O.S. Malattie Degenerative del S.N.C., Napoli, Italy|Ospedale Maggiore della carità - Novara, Novara, Italy|Centro di Riferimento Regionale per la Sclerosi Multipla (CRESM) - SCDO Neurologia, Orbassano, Italy|Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone - Dipartimento di Neuroscienze, Palermo, Italy|Azienda Ospedaliera di Udine Ospedale S. Maria della Misericordia - UO Neurologia, Perugia, Italy|Grande Ospedale Metropolitano "Bianchi Melacrino Morelli - Centro Regionale Epilessia, Reggio Calabria, Italy|Azienda Ospedaliera San Filippo Neri - Neurologia, Roma, Italy|Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza - Dip. di Neurologia e Psichiatria (servizio EMG), Roma, Italy|A. O. U. San Giovanni Di Dio e Ruggi D'Aragona - Struttura Complessa di Oculistica, Salerno, Italy|Azienda Ospedaliera Universitaria Integrata Verona (Ospedale Borgo Roma) - D.U.Neurologia, Verona, Italy|Vestre Viken HF Drammen Sykehus - former Sykehuset Buskerud, Drammen, Norway|Sykehuset Namsos, Namsos, Norway|Oslo Universitetssykehus HF - Ullev?l, Oslo, Norway|Uniwersytecki Szpital Kliniczny w Bialymstoku - Dept of Neurology, Bialystok, Poland|Szpital Specjalistyczny im. L.Rydygiera w Krakowie - Neurology Department, Krakow, Poland|Szpital Uniwersytecki w Krakowie - Uniwersytet Jagiellonski Collegium Medicum, Krakow, Poland|Szpital Kliniczny im.Heliodora Swiecickiego Uniwersytetu Medycznego im.K. Marcinkowskiego w Poznaniu - Dept of Neurology, Poznan, Poland|Pomorski Uniwersytet Medyczny - Klinika Neurologii, Szczecin, Poland|Wojskowy Instytut Medyczny - Klinika Neurologiczna, Warszawa, Poland|SPZOZ Wojewodzki Szpital Specjalistyczny nr 3 w Rybniku, Zory, Poland|Centro Hospitalar de Lisboa Ocidental, E.P.E. - Hospital de Egas Moniz - Servi?o de Neurologia, Lisboa, Portugal|Unidade Local de Saúde de Matosinhos, EPE (Hospital Pedro Hispano) - Servi?o de Neurologia, Matosinhos, Portugal|Centro Hospitalar de S?o Jo?o, E.P.E. - Servi?o de Neurologia, Porto, Portugal|Hospital Garcia de Orta, EPE - Servi?o de Neurologia, Pragal, Portugal|Centro Hospitalar de Setubal, EPE - Hospital S?o Bernardo, Setúbal, Portugal|Unidade Local de Saúde do Alto Minho, EPE - Servi?o de Neurologia, Viana De Castelo, Portugal|Inselspital - Universitaetsspital Bern - Neuropsychologische Rehabilitation, Neurologie, Bern, Switzerland|(CHUV), Centre Hospitalier Universitaire Vaudois - Departement des Neurosciences Cliniques, Lausanne, Switzerland|Ospedale Regionale di Lugano - Neurologia, Lugano, Switzerland|Luzerner Kantonsspital - Zentrum fuer Neurologie und Neurorehabilitation, Luzern 16, Switzerland|H?pital Régional Sion-Hérens-Conthey - Neurologie, Sion, Switzerland Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.50mL

0.70mL

0.35mL

17.50mL

3.50mL

1.75mL

35.00mL

7.00mL

3.50mL

References

 

Historical Records

Categories